Home / Health / AI & Bioterror: Is America Ready?
AI & Bioterror: Is America Ready?
31 Jul
Summary
- AI advancements accelerate biological risks, making US vulnerable.
- US biodefense funding cut while threats from AI grow.
- Measles resurgence signals deep issues in public health readiness.
Rapid advancements in artificial intelligence are significantly increasing biological risks, potentially making the U.S. highly vulnerable to engineered pathogens. Experts express grave concern that AI lowers the barrier for developing sophisticated biological agents that could evade current medical defenses, a threat that may no longer be confined to state actors.
Recent outbreaks, including a large-scale cyclospora contamination linked to iceberg lettuce and a resurgence of measles, have exposed critical weaknesses in U.S. public health infrastructure. Biodefense funding has been reduced, and key surveillance systems like BioWatch have not been updated since 2011, leading to a regression in preparedness.
While some initiatives aim to enhance biosecurity, such as new policies on high-risk life sciences research, significant gaps remain. The ability to design novel biological agents using AI, without corresponding screening mechanisms, presents a concerning future threat. This precarious situation demands urgent attention to strengthen national defenses against evolving biological risks.
The ongoing transmission of measles, a disease once eliminated in the U.S., serves as a stark indicator of declining public health resilience. This, coupled with the slow response to the cyclospora outbreak, underscores the urgent need for improved surveillance, investigation capacity, and robust biodefense strategies to counter both natural and engineered threats.
